1-4 of 4
Daniel Neureiter, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Time-to-Treatment in Chronic Myelomonocytic Leukemia - a Novel Prediction Model

Florian Huemer, MD, Lukas Weiss, MD, Viktoria Faber, MD, Daniel Neureiter, MD, Alexander Egle, MD, Richard Greil, MD, Lisa Pleyer, MD DI
Journal: Blood
Blood (2016) 128 (22): 5547.
https://doi.org/10.1182/blood.V128.22.5547.5547
Published: 2016
Journal Articles

Clonal Evolution in Relapsed or Refractory Diffuse Large B Cell Lymphoma

Thomas Melchardt, MD, Clemens Hufnagl, MSC, Oliver Weigert, MD, David M. Weinstock, MD, Nadja Kopp, MA, Lukas Weiss, MD PhD, Daniel Neureiter, MD, Wolfgang Tränkenschuh, MD, Hubert Hackl, Dr, Richard Greil, MD, Alexander Egle, MD
Journal: Blood
Blood (2014) 124 (21): 77.
https://doi.org/10.1182/blood.V124.21.77.77
Published: 2014
Journal Articles

T Cell Exhaustion Contributes to Immune Evasion in Chronic Lymphocytic Leukaemia

Franz Josef Gassner, PhD, Nadja Zaborsky, PhD, Daniel Neureiter, MD, Michael Huemer, MSc, Alexander Egle, MD, Tanja Nicole Hartmann, PhD, Richard Greil, MD, Roland Geisberger, PhD
Journal: Blood
Blood (2012) 120 (21): 1773.
https://doi.org/10.1182/blood.V120.21.1773.1773
Published: 2012
Journal Articles

Treatment of Aggressive B-Cell Lymphoma in the Elderly: The Influence of SNPs Affecting Pharmacodynamics Is Different Compared to Younger Patient

Thomas Melchardt, MD, Lukas Weiss, MD, Clemens Hufnagl, Daniel Neureiter, MD, Ralf Kemmerling, MD, Patrick Morre, Ann Boekstegers, Georg Hopfinger, MD, Richard Greil, MD, Alexander Egle, MD
Journal: Blood
Blood (2012) 120 (21): 1613.
https://doi.org/10.1182/blood.V120.21.1613.1613
Published: 2012